New patent expiration for Merck Sharp drug JANUMET

00:06 EST 2 Feb 2019 | BiotechBlog

Annual Drug Patent Expirations for JANUMET Janumet is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from one supplier. There are seven…
The post New patent expiration for Merck Sharp drug JANUMET appeared first on Dr...

The post New patent expiration for Merck Sharp drug JANUMET appeared first on Biotechblog.

Original Article: New patent expiration for Merck Sharp drug JANUMET

More From BioPortfolio on "New patent expiration for Merck Sharp drug JANUMET"